Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine.
Revenue is primarily driven by Royalty (54.5%) and Direct Sales Medical Care Providers Gross (45.5%).
No significant events in the past 90 days.
—
Market Cap
—
Revenue
—
Net Income
Revenue by Segment
No significant events in the past 90 days.